Skip to main content

American Neurological Association (ANA), 2024

Clear all
Content type:
Long-term safety outcomes of rozanolixizumab treatment in patients with generalized myasthenia gravis: A pooled analysis
Vissing John, Grosskreutz Julian, Habib A. Ali, et al.